Both primary biliary cholangitis and primary sclerosing cholangitis are slow progressive chronic liver diseases that are caused by bile duct destruction and fibrosis leading to cirrhosis.

However, the pathogenesis of the disease is often unclear, the cause is unknown, and effective treatments are limited.

In this review, promising treatments for cholestatic liver disease are described based on the latest findings and their perspectives.